2,866 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,179 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,179 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.15%65.99% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,866
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
626
$5.58M
627
$5.57M
628
$5.55M
629
$5.54M
630
$5.51M
631
$5.48M
632
$5.46M
633
$5.45M
634
$5.45M
635
$5.45M
636
$5.43M
637
$5.43M
638
$5.43M
639
$5.42M
640
$5.38M
641
$5.37M
642
$5.37M
643
$5.36M
644
$5.34M
645
$5.33M
646
$5.32M
647
$5.3M
648
$5.29M
649
$5.27M
650
$5.23M